Tolerability of Dalpiciclib vs. Abemaciclib/Ribociclib in Early HR+/HER2- Breast Cancer
Conditions : Breast Cancer Interventions : Drug: Dalpiciclib; Drug: Abemaciclib/Ribociclib Sponsors : Henan Cancer Hospital Not yet recruiting
Read the full article2d agoen
Comments
Sign in to join the conversation.
No comments yet. Be the first.